MOTOLA, DOMENICO
 Distribuzione geografica
Continente #
NA - Nord America 7.562
AS - Asia 6.117
EU - Europa 4.865
SA - Sud America 314
Continente sconosciuto - Info sul continente non disponibili 297
AF - Africa 296
OC - Oceania 13
Totale 19.464
Nazione #
US - Stati Uniti d'America 7.434
VN - Vietnam 1.897
SG - Singapore 1.598
CN - Cina 1.367
GB - Regno Unito 1.367
IT - Italia 1.138
DE - Germania 597
HK - Hong Kong 421
SE - Svezia 365
FR - Francia 307
UA - Ucraina 276
IN - India 240
BR - Brasile 233
RU - Federazione Russa 230
IE - Irlanda 175
JP - Giappone 125
ZA - Sudafrica 101
KR - Corea 98
BD - Bangladesh 96
FI - Finlandia 88
NL - Olanda 77
CI - Costa d'Avorio 72
CA - Canada 68
EE - Estonia 58
JO - Giordania 53
TG - Togo 52
BE - Belgio 36
PH - Filippine 35
AR - Argentina 33
MX - Messico 32
ID - Indonesia 29
NG - Nigeria 28
GR - Grecia 21
PK - Pakistan 19
TH - Thailandia 19
AT - Austria 18
PL - Polonia 18
TR - Turchia 17
CH - Svizzera 15
EU - Europa 15
HR - Croazia 15
BG - Bulgaria 14
IQ - Iraq 14
IR - Iran 14
SC - Seychelles 14
AU - Australia 13
TW - Taiwan 12
UZ - Uzbekistan 12
CO - Colombia 11
EC - Ecuador 10
CL - Cile 9
LT - Lituania 9
MY - Malesia 9
LB - Libano 8
VE - Venezuela 8
CR - Costa Rica 7
EG - Egitto 7
CZ - Repubblica Ceca 6
ES - Italia 6
PY - Paraguay 6
RO - Romania 6
SA - Arabia Saudita 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
AL - Albania 5
JM - Giamaica 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
GH - Ghana 3
HN - Honduras 3
KE - Kenya 3
KZ - Kazakistan 3
PT - Portogallo 3
BO - Bolivia 2
GT - Guatemala 2
IL - Israele 2
LC - Santa Lucia 2
LY - Libia 2
MA - Marocco 2
MD - Moldavia 2
MU - Mauritius 2
NP - Nepal 2
PE - Perù 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BT - Bhutan 1
BY - Bielorussia 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
GD - Grenada 1
KG - Kirghizistan 1
LK - Sri Lanka 1
Totale 19.170
Città #
Southend 1.218
Singapore 1.089
Ashburn 633
Fairfield 535
San Jose 521
Santa Clara 517
Chandler 504
Hong Kong 403
Dong Ket 391
Ho Chi Minh City 375
Hanoi 329
Wilmington 260
Princeton 250
Woodbridge 247
Houston 245
Seattle 238
Cambridge 209
Hefei 209
Jacksonville 196
Council Bluffs 191
Ann Arbor 184
Dallas 175
Dublin 174
Beijing 148
Los Angeles 138
Boardman 125
Lauterbourg 120
Tokyo 108
Bologna 106
Nanjing 103
Westminster 94
Padova 91
Seoul 90
Helsinki 77
New York 75
Abidjan 72
Berlin 72
Da Nang 67
Rome 65
Milan 64
Haiphong 63
Bremen 56
Buffalo 54
Amman 53
Lomé 52
Shenyang 52
Mülheim 50
Saint Petersburg 45
Jinan 43
Medford 39
San Diego 39
Frankfurt am Main 38
Munich 38
Nanchang 36
Redondo Beach 36
Changsha 35
Brussels 33
Hebei 31
San Venanzo 31
São Paulo 31
Guangzhou 29
Redmond 28
Shanghai 28
Tianjin 28
London 27
Abeokuta 25
Biên Hòa 25
Florence 25
Phoenix 25
Atlanta 24
Zhengzhou 24
Orem 23
Falls Church 22
Turin 21
Brooklyn 20
San Francisco 20
Hải Dương 19
Jiaxing 19
The Dalles 19
Wuhan 19
Chicago 17
Denver 17
Hangzhou 17
Bengaluru 16
Montreal 16
Toronto 16
Ningbo 15
Palermo 15
Shenzhen 15
Bến Tre 14
Dearborn 14
Haikou 14
Lanzhou 14
Modena 14
Mexico City 13
Nha Trang 13
Nuremberg 13
Olalla 13
Thái Nguyên 13
Yubileyny 13
Totale 12.325
Nome #
Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci? 625
Use of antibiotics in pediatrics: 8-years survey in Italian hospitals 586
Direct-acting oral anticoagulants and alopecia: The valuable support of postmarketing data 372
Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy. 321
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 315
Acute renal failure in patients treated with dronedarone or amiodarone: A large population-based cohort study in Italy 289
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions 288
Le basi della farmacologia 272
Ibuprofen-associated hypothermia in children: analysis of the Italian spontaneous reporting database 258
Drug-Induced Progressive Multifocal Leukoencephalopathy: A Comprehensive Analysis of the WHO Adverse Drug Reaction Database 245
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database. 235
Safety profile of H1-antihistamines in pediatrics: an analysis based on data from VigiBase 232
A 3 year survey on the use of antibacterial agents in five Italian hospitals. 231
Comparative risk/benefit profile of biosimilar and originator erythropoiesis-stimulating agents (ESAs): data from an Italian observational study in nephrology 231
Use of antibacterial agents in Italian hospitals: a 2004 to 2011 drug utilization survey in the Emilia-Romagna region 227
Antibacterial prescription in Italian preschool children: analysis of 7 years of data from the Emilia-Romagna region reimbursement database 219
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy 217
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 216
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 216
Antimicrobials and the Risk of Torsades de Pointes. The Contribution from Data Mining of the US FDA Adverse Event Reporting System 214
Ticlopidine Safety Profile: A Case/Non-Case Study on the Basis of the Spontaneous ADRs Reporting in Italy 213
Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions 209
Drug-induced disseminated intravascular coagulation: a pharmacovigilance study on World Health Organization’s database 207
Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature 204
Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region). 196
Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database 194
Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. 192
An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals. 191
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. 191
An update on the first decade of the European centralized procedure: how many innovative drugs? 190
Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting 189
Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions 188
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 187
Comparative Safety Profiles of Oncology Biosimilars vs. Originators in Europe: An Analysis of the EudraVigilance Database 183
Signal detection activity on EudraVigilance data: analysis of the procedure and findings from an Italian Regional Centre for Pharmacovigilance 182
Human papilloma virus vaccination in males: A pharmacovigilance study on the Vaccine Adverse Event Reporting System 181
Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug's safety profile. 180
Antidepressant-Induced Acute Liver Injury: A Case–Control Study in an Italian Inpatient Population 180
Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug’s safety profile. 178
Changes in prevalence and pattern of drug use in a ten years period in Italy. 8th Congress of the European Association for Clinical Pharmacology and Therapeutics 175
Comparative Safety Profiles of Biosimilars vs. Originators Used in Rheumatology: A Pharmacovigilance Analysis of the EudraVigilance Database 171
Possible occurrence of paraesthesia in patients taking norethisterone: an analysis on the WHO Global Individual Case Reports database (VigiBase). 171
Off-label use of nicardipine as tocolytic and acute pulmonary oedema: A post-marketing analysis of adverse drug reaction reports in EudraVigilance 171
Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data 170
Dronedarone-associated acute renal failure: evidence coming from the Italian spontaneous ADR reporting database 168
Safety Profile of Molnupiravir in the Treatment of COVID-19: A Descriptive Study Based on FAERS Data 167
Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System. 167
Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017 167
Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy 162
Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy 160
Hepatic adverse drug reactions: a case/non-case study in Italy 159
Off-label use of nicardipine as tocolytic and acute pulmonary oedema: evidence from EudraVigilance 158
Non-commercial trials on medicines submitted to the Ethics Committee of the University Hospital of Bologna (Italy) along 8 years of activity: time to update rules and recommendations 157
A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital. 156
Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database 156
Antibiotic use in Italian hospitals 2002-2004. 155
Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy 155
Six-year activity on approval of compassionate use of medicines by the Ethics Committee of the University Hospital of Bologna (Italy): time to update rules and recommendations 154
Pattern of NSAID use in the Italian general population: a questionnaire-based survey. 153
Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy 152
Infarto del miocardio, edema maculare e fratture associate ai glitazoni: analisi del database di segnalazione spontanea FDA_AERS 152
Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in Italy 150
Progressive Multifocal Leukoencephalopathy: an effect of immunodeficiency or an adverse drug reaction? 148
Level of therapeutic innovation from the registration studies of the new drugs for the prophylaxis of migraine 147
Pioglitazone-associated bladder cancer: the contribution of spontaneous reporting analysis on the basis of FDA_AERS database 146
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases 146
Use and Safety Profile of Antiepileptic Drugs in Italy. 145
Safety profile of thiazolidinediones on the basis of the FDA-AERS database: cardiovascular and bone fracture risks for rosiglitazone and pioglitazone 145
Therapeutic innovation of the drugs approved by the EMEA-centralised procedure 144
Initial treatment of hypertension and adherence to therapy in general practice in Italy 144
Un commento alla lettera sulla definizione di farmaco innovativo 143
Farmacosorveglianza: la segnalazione delle reazioni avverse da farmaci in Emilia-Romagna nel 2011 142
PAttern of drug use in PEdiatrics: An observational study in Italian hOSpitals (the PAPEOS study) 141
Allergic reactions to oral drugs: A case/non-case study from an Italian spontaneous reporting database (GIF). 137
Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital. 136
Progressive Multifocal Leukoencephalopathy (PML): only immunosuppressive complication or also drug adverse reaction? 133
The prescription of antimicrobials by general practitioners: the differences between north and south Italian provinces 133
Safety profile of paediatric COVID-19 vaccines: An analysis of the US Vaccine Adverse Event Reporting System 132
Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database. 132
Farmaci EMEA ed innovazione terapeutica 132
Adverse event reporting with immune checkpoint inhibitors in older patients: Age subgroup disproportionality analysis in vigibase 129
Allergic Reactions to Oral Drugs: A Case/Non Case Study from an Italian Spontaneous Reports Database (GIF). 128
Post-approval safety issues with innovative drugs: a European cohort study. 126
Pattern of Triptan Use in a Sample of the Italian General Population 125
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice 125
The Influence of Notoriety Bias on ADR Spontaneous Reporting Rate. 124
Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting. 123
Prevenire gli errori in terapia. Strategie per i farmacisti 121
Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database. 121
Removal of the EMA orphan designation upon request of the sponsor: cui prodest? 118
Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy 117
Drug-Induced Taste and Smell Alterations: A Case/Non-Case Study on an Italian Database of Adverse Drug Reactions. 116
Underreporting in pharmacovigilance among the GPs from three Local Health Authority in Italy 115
Ticlopidine’s safety profile: a case/non case study on the basis of the spontaneous ADR reporting in Italy. 112
Incretin-mimetics associated pancreatitis: evidence from the spontaneous adverse drug reactions reporting in Italy 112
Finasteride e carcinoma mammario nell'uomo. Prima segnalazione di sospetta ADR in Italia 111
Use and safety profile of antiepileptic drugs. 107
Signal detection in spontaneous reporting database: Data from GIF, an Italian inter-regional database. 106
Appropriatezza d'impiego dei tiazolidindioni nell'Azienda Ospedaliera di Ferrara 106
Generic versus brand-name medicinal products: are they really interchangeable? 104
Totale 18.022
Categoria #
all - tutte 51.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.395


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.622 0 0 119 120 182 88 42 130 71 100 441 329
2022/20232.137 214 302 144 290 141 185 36 107 386 59 180 93
2023/2024648 52 89 47 90 51 54 45 57 21 69 47 26
2024/20252.452 90 327 190 139 591 176 133 84 43 76 112 491
2025/20266.366 419 457 561 499 723 301 1.027 280 1.069 475 341 214
2026/2027733 433 289 11 0 0 0 0 0 0 0 0 0
Totale 19.464